Related references
Note: Only part of the references are listed.Development of new vaccines and drugs for TB: limitations and potential strategic errors
Ian M. Orme
FUTURE MICROBIOLOGY (2011)
Phenotypic Definition of Effector and Memory T-Lymphocyte Subsets in Mice Chronically Infected with Mycobacterium tuberculosis
Marcela I. Henao-Tamayo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Update on Research and Development Pipeline: Tuberculosis Vaccines
Belinda Beresford et al.
CLINICAL INFECTIOUS DISEASES (2010)
Epidemiology and Challenges to the Elimination of Global Tuberculosis
Mandeep S. Jassal et al.
CLINICAL INFECTIOUS DISEASES (2010)
Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis
Shahin Shafiani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved
Inaki Comas et al.
NATURE GENETICS (2010)
The Population Dynamics and Control of Tuberculosis
Christopher Dye et al.
SCIENCE (2010)
A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
Sylvie Bertholet et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Trends in tuberculosis incidence and their determinants in 134 countries
C. Dye et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2009)
Evolutionary pathway of the Beijing lineage of Mycobacterium tuberculosis based on genomic deletions and mutT genes polymorphisms
Laura Rindi et al.
INFECTION GENETICS AND EVOLUTION (2009)
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance
Abigail Wright et al.
LANCET (2009)
Clinical strains of Mycobacterium tuberculosis display a wide range of virulence in guinea pigs
Gopinath S. Palanisamy et al.
TUBERCULOSIS (2009)
Evaluation of new vaccines for tuberculosis in the guinea pig model
Ann Williams et al.
TUBERCULOSIS (2009)
Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis
Ronggai Sun et al.
VACCINE (2009)
Challenges in estimating the total burden of drug-resistant tuberculosis
Ted Cohen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Mycobacterium bovis BCG Immunization Induces Protective Immunity against Nine Different Mycobacterium tuberculosis Strains in Mice
Bo Young Jeon et al.
INFECTION AND IMMUNITY (2008)
Multidrug-resistant and extensively drug-resistant tuberculosis: The National Institute of Allergy and Infectious Diseases research agenda and recommendations for priority research
Anthony S. Fauci
JOURNAL OF INFECTIOUS DISEASES (2008)
rBCG Induces Strong Antigen-Specific T Cell Responses in Rhesus Macaques in a Prime-Boost Setting with an Adenovirus 35 Tuberculosis Vaccine Vector
Isabelle Magalhaes et al.
PLOS ONE (2008)
Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model
Gopinath S. Palanisamy et al.
TUBERCULOSIS (2008)
BCG vaccination confers poor protection against M-tuberculosis HN878-induced central nervous system disease
Liana Tsenova et al.
VACCINE (2007)
The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation
Diane Ordway et al.
JOURNAL OF IMMUNOLOGY (2007)
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
Shabaana A. Khader et al.
NATURE IMMUNOLOGY (2007)
Worldwide emergence of extensively drug-resistant tuberculosis
N. Sarita Shah et al.
EMERGING INFECTIOUS DISEASES (2007)
The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guerin (BCG) vaccines: is there a link?
F. Abebe et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Advances in tuberculosis vaccine strategies
Yasir A. W. Skeiky et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Hypervirulent M-tuberculosis W/Beijing strains upregulate type IIFNs and increase expression of negative regulators of the Jak-Stat pathway
C Manca et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2005)
Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin
L Grode et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis
AG Tsolaki et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis
C Manca et al.
INFECTION AND IMMUNITY (2004)
Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers
K Kremer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains
PJ Bifani et al.
TRENDS IN MICROBIOLOGY (2002)
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β
C Manca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
